Two small companies developing therapeutic vaccines against hypertension are blazing a trail for immune treatments that address diseases of lifestyle with massive markets. But doubts linger over the ...

Angiotensin II receptor blockers (ARBs) are drugs that treat certain conditions affecting the heart and blood vessels as well as a kidney condition resulting from diabetes. People generally tolerate ...

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients ...

Hennigsdorf/ Berlin, Germany, September 16, 2020 - 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announces data on the efficacy of its lead product, Procizumab, that promptly restored cardiac dysfunction in ...

June 23, 2015 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Head office: Chuo-ku, Tokyo; Chairman & CEO: Osamu Nagayama] announced today that the long-term data of phase I/II study (ACE002JP) was ...